Remove Medical Remove Pharmaceutical Remove Safety
article thumbnail

Medical Grade Skincare vs. Over-the-Counter Products: What’s the Difference?

Kim Gallo Esthetics

Are you wondering what the difference is between medical-grade skincare products and over-the-counter products? In this blog post, we will discuss the key differences between medical-grade skincare and over-the-counter products - so you can decide which route is best for you. What is medical-grade skincare?

article thumbnail

Oh, The Places Dermatology Will Go in 2024!

The Dermatology Digest

In 2023, dermatologists and their patients welcomed new drugs for acne, psoriasis, alopecia areata, and more, and 2024 promises to deliver real-world data on these medications along with even more therapeutic innovations across the spectrum of cutaneous diseases. We will, for sure, have new medications for chronic urticaria.”

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Retinol Serum: Is It Safe for Kids and Teens?

First Derm

Social media significantly influences the popularity of retinol among young people, leading to increased experimentation without considering safety. There’s a crucial difference between cosmetic retinol use and medical treatment with retinoids ; the latter is for specific skin conditions under professional supervision.

Retinol 104
article thumbnail

Topline Results: Verrica’s VP-315 Performs Well in BCC Trial

The Dermatology Digest

Verrica Pharmaceuticals Inc.’s The Phase 2 trial is a 2-part, open-label, multicenter, dose-escalation, proof-of-concept study with a safety run-in designed to assess the safety and tolerability, pharmacokinetics, and efficacy of VP-315 when administered intratumorally to adults with biopsy-proven basal cell carcinoma.

Safety 36
article thumbnail

Biosimilar News: FDA Approves Simlandi as Third Interchangeable Humira Biosimilar

The Dermatology Digest

. “The approval of SIMLANDI marks the first high-concentration, citrate-free biosimilar to Humira with IC status,” says Dr. Eric Hughes, Executive Vice President Global R&D and Chief Medical Officer at Teva, in a news release. where biologics represent well over 40% of all pharmaceutical spending.

Safety 36
article thumbnail

TDD Industry News and Views: Weekly Updates on Comings, Goings, and Other Happenings in Dermatology

The Dermatology Digest

Verrica Pharmaceuticals Files Lawsuit Against Canadian Drug Manufacturer for False Advertising, Unfair Competition Verrica Pharmaceuticals Inc. Verrica Pharmaceuticals Files Lawsuit Against Canadian Drug Manufacturer for False Advertising, Unfair Competition Verrica Pharmaceuticals Inc.

article thumbnail

Who Can Administer Botox?

AAAMS

Botox and dermal fillers are powerful treatments for a wide range of aesthetic and medical conditions, but they require precise application from skilled and certified professionals. Licensed medical professionals can only purchase this controlled substance through pharmaceutical supply chains. Can Aestheticians Administer Botox?